- Home
- ANVS vs FEIM Comparison
ANVS vs FEIM Comparison
Compare ANVS & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- FEIM
- Stock Information
- Founded
- ANVS 2008
- FEIM 1961
- Country
- ANVS United States
- FEIM United States
- Employees
- ANVS N/A
- FEIM N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- FEIM Electrical Products
- Sector
- ANVS Health Care
- FEIM Industrials
- Exchange
- ANVS Nasdaq
- FEIM Nasdaq
- Market Cap
- ANVS 42.9M
- FEIM 291.0M
- IPO Year
- ANVS 2020
- FEIM N/A
- Fundamental
- Price
- ANVS $1.64
- FEIM $37.52
- Analyst Decision
- ANVS Strong Buy
- FEIM Strong Buy
- Analyst Count
- ANVS 4
- FEIM 1
- Target Price
- ANVS $17.33
- FEIM $43.00
- AVG Volume (30 Days)
- ANVS 1.1M
- FEIM 314.8K
- Earning Date
- ANVS 11-07-2025
- FEIM 09-11-2025
- Dividend Yield
- ANVS N/A
- FEIM N/A
- EPS Growth
- ANVS N/A
- FEIM 264.74
- EPS
- ANVS N/A
- FEIM 2.27
- Revenue
- ANVS N/A
- FEIM $68,546,000.00
- Revenue This Year
- ANVS N/A
- FEIM N/A
- Revenue Next Year
- ANVS N/A
- FEIM $17.90
- P/E Ratio
- ANVS N/A
- FEIM $16.52
- Revenue Growth
- ANVS N/A
- FEIM 18.30
- 52 Week Low
- ANVS $1.11
- FEIM $12.17
- 52 Week High
- ANVS $10.54
- FEIM $39.66
- Technical
- Relative Strength Index (RSI)
- ANVS 24.25
- FEIM 60.78
- Support Level
- ANVS $1.88
- FEIM $35.78
- Resistance Level
- ANVS $2.60
- FEIM $39.14
- Average True Range (ATR)
- ANVS 0.15
- FEIM 2.10
- MACD
- ANVS -0.04
- FEIM 0.43
- Stochastic Oscillator
- ANVS 5.34
- FEIM 81.47
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.